Previous Page  5 / 10 Next Page
Information
Show Menu
Previous Page 5 / 10 Next Page
Page Background

Page 15

Notes:

J Med Oncl Ther 2017 | Volume 2 Issue 4

allied

academies

Oncology and Biomarkers Summit

November 27-28, 2017 | Atlanta, USA

Annual Congress on

T

he level of hypoxia-inducible factor 1a (HIF-1a) plays

an important role not only in the development of in

hepatocellular carcinoma (HCC), but also in its metastasis,

recurrence and resistance to anti-tumor chemotherapy. ZBP-

89 is a transcription factor that binds to gene promoter GC-

rich sequence to activate or suppress the transcription of

genes that are associated with cell growth and cell death.

However, the relationship between HIF-1a and ZBP-89 is

unknown in HCC. In this study, we examined the levels of

HIF-1a and ZBP-89 in HCC cells and HCC tissue samples. We

found that the expression of HIF-1a was significantly in all

HCC tumor samples, compared with non-tumor liver tissues.

The levels of ZBP-89 was slightly increased in the well-

differential HCC tumor samples but obviously decreased in

moderately or poorly differential tumor samples, compared

with non-tumor liver tissue samples. Overall, the expression

of ZBP-89 was inversely correlated with the stage of the

tumor differentiation and the level of HIF-1a in HCC samples,

indicating that the higher HIF-1a, the lower ZBP-89. In

conclusion, there is a negative relationship between the

level of HIF-1a and the expression of ZBP-89 in HCC. The data

suggest that the low level of ZBP-89 may contribute to the

upregulation of HIF-1a. Considering the fact that ZBP-89 can

induce apoptosis in HCC cells, whether upregulation of ZBP-

89 will negatively impact the expression of HIF-1a remains an

interesting question.

Speaker Biography

George G Chen is a Professor in the Department of Surgery, Director of Surgical

Research Laboratories and Faculty of Medicine of Chinese University of Hong Kong,

China. He has extensive experience in cancer research, particularly in the area of liver

and lung cancers. He has authored or co-authored more than 200 papers and has

written a number of books or book chapters.

e:

gchen@cuhk.edu.hk

George G Chen

The Chinese University of Hong Kong, China

ZBP-89 and hypoxia-inducible factor 1a in hepatocellular carcinoma